Mesoblast Limited
MESO
$16.11
$0.090.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.10M | -27.10M | -23.97M | -23.97M | -27.71M |
| Total Depreciation and Amortization | 2.16M | 2.16M | 1.04M | 1.04M | 1.11M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.62M | 11.62M | 12.79M | 12.79M | 14.65M |
| Change in Net Operating Assets | -1.33M | -1.33M | -195.00K | -195.00K | 1.00M |
| Cash from Operations | -14.65M | -14.65M | -10.33M | -10.33M | -10.94M |
| Capital Expenditure | -287.00K | -287.00K | -53.00K | -53.00K | -38.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.50K | 33.50K | 366.50K | 366.50K | 34.00K |
| Cash from Investing | -253.50K | -253.50K | 313.50K | 313.50K | -4.50K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.09M | -3.09M | -1.79M | -1.79M | -5.69M |
| Issuance of Common Stock | 82.52M | 82.52M | 670.50K | 670.50K | 12.85M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.63M | -3.63M | -1.01M | -1.01M | -2.83M |
| Cash from Financing | 75.80M | 75.80M | -2.13M | -2.13M | 4.33M |
| Foreign Exchange rate Adjustments | 864.00K | 864.00K | -319.50K | -319.50K | -675.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 61.76M | 61.76M | -12.47M | -12.47M | -7.30M |